Pantoprazole based therapies in Helicobacter pylori eradication: A systematic review and meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 1, 2004, Pages 89-99

  Gisbert, Javier P ^a,c   Khorrami, Sam ^a   Calvet, Xavier ^b   Pajares, José María ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

^c NONE   (Spain)

Author keywords

Helicobacter pylori; Meta analysis; Omeprazole; Pantoprazole; Proton pump inhibitor; Systematic review; Therapy

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RIFABUTIN; ROXITHROMYCIN; TETRACYCLINE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIINFECTIVE AGENT; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; PROTON PUMP; SULFOXIDE;

CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; DRUG EFFICACY; ELECTRONICS; ERADICATION THERAPY; EVALUATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LITERATURE; META ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-INFECTIVE AGENTS; BENZIMIDAZOLES; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; SULFOXIDES;

EID: 3042785640     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200401000-00014     Document Type: Review

References (98)

1. Huber R, Kohl B, Sachs G, Senn-Bilfinger J, Simon WA, Sturm E. Review article: the continuing development of proton pump inhibitors with particular reference to pantoprazole. Aliment Pharmacol Ther 1995; 9:363-378.
2. Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996; 51:460-482.
3. Parsons ME. Pantoprazole, a new proton-pump inhibitor, has a precise and predictable profile of activity. Eur J Gastroenterol Hepatol 1996; 8 (suppl 1):S15-S20.
4. Gisbert JP, Boixeda D, Martin de Argila C, Garcia Plaza A. [Role of pantoprazole in the eradicating treatment of Helicobacter pylori.] Rev Clin Esp 1998; 198:678-683.
5. Thomson AB. Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. Curr Gastroenterol Rep 2000; 2:482-493.
6. Horn J. The proton-pump inhibitors: similarities and differences. Clin Ther 2000; 22:266-280; discussion 265.
7. Jungnickel PW. Pantoprazole: a new proton pump inhibitor. Clin Ther 2000; 22:1268-1293.
8. Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14:963-978.
9. Poole P. Pantoprazole. Am J Health Syst Pharm 2001; 58:999-1008.
10. Gisbert JP, Pajares JM. Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis 2001; 19:134-143.
11. Suerbaum S, Leying H, Klemm K, Opferkuch W. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10:92-93.
12. Nakao M, Malfertheiner P. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori. Helicobacter 1998; 3:21-27.
13. Dattilo M, Figura N. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors. J Clin Gastroenterol 1998; 27 (suppl 1):S163-S169.
14. Hartmann M, Theiss U, Huber R, Luhmann R, Bliesath H, Wurst W, et al. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Aliment Pharmacol Ther 1996; 10:359-366.
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12.
16. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16:167-180.
17. Asaka M, Satoh K, Sugano K, Sugiyama T, Takahashi S, Fukuda Y, et al. Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 2001; 6:177-186.
18. Howden CW, Hunt RH. Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998; 93:2330-2338.
19. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13:1-12.
20. Coelho LG, Leon-Barua R, Quigley EM. Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE). Am J Gastroenterol 2000; 95:2688-2691.
21. Gisbert JP, Calvet X, Gomollon F, Sainz R. [Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference.] Med Clin (Barc) 2000; 114:185-195.
22. Gasbarrini A, Ojetti V, Pitocco D, Franceschi F, Candelli M, Torre ES, et al. Insulin-dependent diabetes mellitus affects eradication rate of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1999; 11:713-716.
23. Gasbarrini A, Ojetti V, Pitocco D, Armuzzi A, Silveri NG, Pola P, et al. Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. Scand J Gastroenterol 2000; 35:260-263.
24. Ojetti V, Pitocco D, Ghirlanda G, Gasbarrini G, Gasbarrini A. [Role of Helicobacter pylori infection in insulin-dependent diabetes mellitus.] Minerva Med 2001; 92:137-144.
25. Dalla Liebera M, Bramati S, Bovo G, Dell'Acqua D, Rivlta R, Panelli MR, et al. Re-treatment of patients with persistent Helicobacter pylori infection [Abstract]. Gastroenterology 1999; 116:G622.
26. Perri F, Festa V, Clemente R, Villani MR, Quitadamo M, Caruso N, et al. Randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol 2001; 96:58-62.
27. Boixeda D, Bermejo F, Martin-De-Argila C, Lopez-Sanroman A, Defarges V, Hernandez-Ranz F, et al. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16:1457-1460.
28. Perri F, Festa V, Clemente R, Quitadamo M, Andriulli A. Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther 2000; 14:311-316.
29. Adamek RJ, Bethke TD. Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The International Pantoprazole HP Study Group. Am J Gastroenterol 1998; 93:1919-1924.
30. Dehesa M, Larisch J, Dibildox M, Vega B, Di Silvio M, Rodriguez L, et al. [Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer.] Rev Gastroenterol Mex 1998; 63:66-71.
31. Svoboda P, Kantorova I, Ochmann J, Doubek J, Kozumplik L, Marsova J. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial. Hepatogastroenterology 1997; 44:886-890.
32. Cammarota G, Papa A, Cianci R, Cannizzaro O, Armuzzi A, Gasbarrini A, et al. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study. Eur J Gastroenterol Hepatol 1999; 11:247-250.
33. Calabrese C, Di Febo G, Areni A, Scialpi C, Biasco G, Miglioli M. Pantoprazole, azithromycin and tinidazole: short duration triple therapy for eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14:1613-1617.
34. Caselli M, Ruina M, Sartori S, Trevisani L, Chiamenti CM, Dentale A, et al. Ultra short-term triple therapy with azithromycin, tinidazole and pantoprazole appears highly effective for Helicobacter pylori eradication [Abstract]. Gastroenterology 1998; 114:G0348.
35. Ruiz Gómez FA, Sanchez Serrano FJ, Martinez Egea A, Garcia Del Castillo G, Sanchez Cuenca J, Coronas Planas M. [Intravenous 3-day Helicobacter pylori eradication therapy is highly effective in patients with bleeding peptic ulcer.] Gastroenterol Hepatol 2002; 25:383-386.
36. Di Mario F, Dal Bo N, Battaglia G, Pilotto A, Franceschi F, Marin R, et al. Are 6 days of a triple clarithromycin based therapy sufficient to obtain the cure of H. pylori infection? [Abstract]. Gut 1999; 45 (suppl III):A121.
37. Dominguez-Martin A, Dominguez-Muñoz A, Muñoz S, Alonso JB, Gonzalez MD. Efficacy of six days triple therapy with pantoprazole plus clarithromycin and amoxycillin versus omeprazole plus clarithromycin and amoxycillin for H. pylori eradication [Abstract]. Gastroenterology 1998; 114:A107.
38. Seelis RE, Dohmen W. [Short-term (6 days) eradication of Helicobacter pylori infection in the practice of a health insurance physician.] Dtsch Med Wochenschr 1998; 123:103-108.
39. Abdul Aal GM, Daj'ani AI, Nounou M, Awad S, Abdul Rasheed Z, Gautam S, et al. Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week. Digestion 1999; 60:286-297.
40. Battaglia G, Benedetti E, Bottona E, Caroli A, Costan F, Chilovi F, et al. Pantoprazole in eradication of peptic ulcer in H. pylori (Hp) positive patients: a multicentre randomized prospective study by GISU (Interdisciplinary Ulcer Study Group) [Abstract]. Gastroenterology 1999; 116:2641.
41. Buzás GM, Illyes G, Szekely E, Szeles I. Six regimens for the eradication of Helicobacter pylori (Hp) in duodenal ulcer patients: three consecutive trials (1995-1999). J Physiol (Paris) 2001; 95:437-441.
42. Dajani Al, Awad S, Ukabam S, Nounou MA, Abdul Rasheed Z, Gautam S, et al. One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases. Digestion 1999; 60:298-304.
43. Dehesa M, Larisch J, Di Silvio M, Dibildox M, Almaguer I, Gonzalez G, et al. Comparison of three seven days pantoprazole (panto) based Helicobacter pylori (Hp) eradication schemes in a Mexican population with highly metronidazole (met) resistant Hp strains [Abstract]. Gastroenterology 1998; 114:A283.
44. Frevel M, Daake H, Janisch HD, Kellner HU, Krezdorn HG, Tanneberger D, et al. Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens. Aliment Pharmacol Ther 2000; 14:1151-1157.
45. Gasbarrini A, De Luca A, Fiore G, Gabrielli M, Franceschi F, Ojetti V, et al. Beneficial effects of Helicobacter pylori eradication on migraine [Abstract]. Gastroenterology 1998; 114:G0528.
46. Gisbert JP, Carpio D, Marcos S, Gisbert JL, Garcia Gravalos R, Pajares JM. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2000; 12:489-495.
47. Goh K, Parasakthi N, Cheah P, Ranjeev C, Rosmawati M, Tan Y, et al. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients. J Gastroenterol Hepatol 2000; 15:910-914.
48. Katelaris PH, Crotty B, Reiner R, Radford-Smith G, Bolin T, M. K, et al. A randomized multicentre comparison of pantoprazole quadruple and triple therapies versus bismuth triple therapy in H. pylori positive, endoscopy negative dyspepsia [Abstract]. Gastroenterology 2000; 118:A879.
49. Labenz J, Tillenburg B, Weismuller J, Lutke A, Stolte M. Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer. Aliment Pharmacol Ther 1997; 11:95-100.
50. Lamouliatte H, Samoyeau R, De Mascarel A, Megraud F. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 1999; 13:1523-1530.
51. Louw JA, van Rensburg CJ, Hanslo D, Grundlings HD, Girdwood AH, Marks IN. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. Aliment Pharmacol Ther 1998; 12:545-550.
52. Luna P, del Castillo G, Farias R, Zerbo O, Romanelli O, Dezi R, et al. Efficacy and tolerability of a seven-day triple scheme with pantoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori [Abstract]. Gastroenterology 1997; 112:A202.
53. Pilotto A, Dal Bo N, Franceschi F, Bozzola L, Salandin S, Novelle R, et al. Comparison of three proton pump inhibitors (PPI) in combination with amoxycillin and metronidazole for one week to cure Helicobacter pylori infection in the elderly [Abstract]. Gut 1998; 43 (suppl 2):A91.
54. Pilotto A, Leandro G, Franceschi M, Rassu M, Bozzola L, Furlan F, et al. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther 1999; 13:667-673.
55. Pilotto A, Di Mario F, Franceschi M, Leandro G, Battaglia G, Germana B, et al. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. Aliment Pharmacol Ther 2000; 14:1077-1082.
56. Pilotto A, Franceschi M, Leandro G, Bozzola L, Rassu M, Soffiati G, et al. Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. Aliment Pharmacol Ther 2001; 15:1031-1036.
57. Rinaldi V, Zullo A, De Francesco V, Hassan C, Winn S, Stoppino V, et al. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy. Aliment Pharmacol Ther 1999; 13:163-168.
58. Perri F, Villani MR, Festa V, Quitadamo M, Andriulli A. Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'. Aliment Pharmacol Ther 2001; 15:1023-1029.
59. Salces I, Soto S, Diaz-Tasende J, Castellano G, Yela C, Morillas JD, et al. Estudio comparativo de 3 pautas de erradicacion de H. pylori [Abstract]. Rev Esp Enferm Dig 2001; 93 (suppl I)1:156.
60. Vcev A, Stimac D, Ivandic A, Vceva A, Takac B, Pezerovic D. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. Aliment Pharmacol Ther 2000; 14:69-72.
61. Vcev A, Vceva A, Kurbel S, Takac B, Stimac D, Ivandic A, et al. Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial). Wien Klin Wochenschr 2001; 113:939-941.
62. Adamek RJ, Szymanski C, Pfaffenbach B, Opferkuch W, Ricken D, Wegener M. [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection.] Dtsch Med Wochenschr 1995; 120:358-360.
63. Adamek RJ, Szymanski C, Ffaffenbach B. Pantoprazole versus omeprazole in one-week low-dose triple therapy for cure of H. pylori infection. Am J Gastroenterol 1997; 92:1949-1950.
64. Adamek RJ, Ffaffenbach B, Szymanski C. Cure of H. pylori infection using a 7-day triple therapy combining pantoprazote with two antibiotics. Helicobacter 1998; 3:206-211.
65. Adamek RJ, Szymanski C, Pfaffenbach B. Pantoprazole suppresses Helicobacter pylori without affecting cure. Helicobacter 1999; 4:266-271.
66. Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M, et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 2001; 63:1-7.
67. Bardhan KD, Dillon J, Axon AT, Cooper BT, Tildesley G, Wyatt JI, et al. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazote once versus twice daily. Aliment Pharmacol Ther 2000; 14:59-67.
68. Dammann HG, Folsch UR, Hahn EG, von Kleist DH, Klor HU, Kirchner T, et al. Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. Helicobacter 2000; 5:41-51.
69. Eisig JN, Boaventura S, Chehter EZ, Silva FM, Hashimoto C, Suva JJ, et al. One week treatment with pantoprazole, metronidazole and clarithromycin for Helicobacter pylori eradication in duodenal ulcer patients [Abstract]. Gastroenterology 2000; 118:A1231.
70. Ellenrieder V, Fensterer H, Waurick M, Adler G, Glasbrenner B. Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12:613-618.
71. Ellenrieder V, Boeck W, Richter C, Marre R, Adler G, Glasbrenner B. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol 1999; 34:750-756.
72. Labenz J, Peitz U, Tillenburg B, Becker T, Borsch G, Stolte M. [Short-term triple therapy with pantoprazole, clarithromycin and metronidazole in eradication of Helicobacter pylori.] Leber Magen Darm 1995; 25:122-127.
73. Meier R, Wettstein A, Drewe J, Geiser HR. Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication. Aliment Pharmacol Ther 2001; 15:851-855.
74. Pazzi P, Scagliarini R, Gamberini S, Matarese V, Rizzo C, Gullini S. Short-term low-dose pantoprazoie-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients. Aliment Pharmacol Ther 1998; 12:731-734.
75. Schweeger I, Fitscha P, Sinzinger H. Successful eradication of Helicobacter pylori as determined by (13)C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res 2000; 97:411-420.
76. Wurzer H, Kratochvil P, Stupnicki T, Group APS. Eradication of Helicobacter pylori by means of a low-dose one-week triple therapy containing pantoprazole, clarithromycin and metronidazole [Abstract]. Gastroenterology 1998; 114:G1368.
77. Willkomm G, Birkner B, Fink R, Kunze R, Saitner M, Schepp W. Pantoprazole plus azithromycin and metronidazole for cure of Helicobacter pylori infection [Abstract]. Gastroenterology 1998; 114:G1355.
78. Bock H, Mares H. Short-term triple regimen for eradication of H. pylori with roxithromycin [Abstract]. Gastroenterology 1998; 114-.G0311.
79. Glaser J, Hein J, Daikeler R, Weithofer G, Vieth M, Schmidt M, et al. [Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection.] Med Klin 1998; 93:65-69.
80. Pilotto A, Leandro G, Franceschi M, Bierti L, Di Battista R, Notarbartolo A, et al. Rapid improvement of symptomatology with pantoprazole, amoxycillin and metronidazole in Helicobacter pylori-positive duodenal ulcer patients. Hepatogastroenterology 1999; 46:245-251.
81. Vukobrat-Bijedic Z, Lacevic N, Bratovic I, Gribajcevic M, Gogov B, Radovic S. [Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer.] Med Arh 2000; 54:21-24.
82. Catalano F, Branciforte G, Catanzaro R, Bentivegna C, Cipolla R, Nuciforo G, et al. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy. Helicobacter 1999; 4:178-184.
83. Kyzekova J, Mour J. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. Hepatogastroenterology 1999; 46:2048-2056.
84. Kyzekova J, Arlt J, Arltova M. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection? Hepatogastroenterology 2001; 48:594-602.
85. Ramirez-Barba EJ, Zarate AR, Di Silvio M, Mendoza A, Lopez-Gaytan T, Sanchez-Gonzalez JM, et al. Eradication index of Helicobacter pylori (Hp) with pantoprazole (panto) + clarithromycin (cla) + amoxicillin (amo) for ten days: an open, monocentric study: preliminary report [Abstract]. Gastroenterology 1998; 114:G1084.
86. Bielanski W, Ziemniak W, Plonka M, Dobrzanska MJ, Kaminska A, Konturek SJ. Improvement of anti-Helicobacter pylori therapy by the use of commercially available probiotics [Abstract]. Gut 2002; 51 (suppl II):A98.
87. Bardhan KD, Morton D, Slater DN, Perry MJ, Cherian P, Jones RB, et al. Pantoprazole-based 10-day triple therapy is effective in Helicobacter pylori eradication. Aliment Pharmacol Ther 1998; 12:185-189.
88. Stolzle L, Klann H, Topf G, Seib HJ. Ten-day treatment with pantoprazole, amoxiciltin and metronidazote for cure of Helicobacter pylori [Abstract]. Gastroenterology 1997; 112:A299.
89. Witzel L, Leder K. Cure of Helicobacter pylori in duodenal ulcer disease with triple therapy consisting of pantoprazole, clarithromycin and metronidazole [Abstract]. Gastroenterology 1997; 112:A332.
90. Catalano F, Catanzaro R, Branciforte G, Bentivegna C, Cipolla R, Brogna A, et al. Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up. J Clin Gastroenterol 2000; 31:130-136.
91. Unge P. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 1997; 113:S131-S148.
92. Huang J, Hunt RH, The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Aliment Pharmacol Ther 1999; 13:719-729.
93. Pipkin GA, Williamson R, Wood JR. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12:823-837.
94. Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection - a meta-analysis. Aliment Pharmacol Ther 1999; 13:857-864.
95. Gisbert JP, Gonzalez L, Calvet X, Garcia N, Lopez T, Roque M, et al. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000; 14:1319-1328.
96. Vallve M, Vergara M, Gisbert JP, Calvet X. Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. Aliment Pharmacol Ther 2002; 16:1149-1156.
97. Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14:603-609.
98. Labenz J, Idstrom JP, Tillenburg B, Peitz U, Adamek RJ, Borsch G. One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. Aliment Pharmacol Ther 1997; 11:89-93.